Cipher Pharmaceuticals Inc Stock Other OTC
Stocks
CA17253X1050
Pharmaceuticals
OTC Markets Traded| Market Cap | 347M 243M 218M 203M 184M 23.23B 349M 2.44B 954M 11.99B 913M 893M 38.57B | P/E 2026 * |
12.1x | P/E 2027 * | 11.2x |
|---|---|---|---|---|---|
| Enterprise Value | 347M 243M 218M 203M 184M 23.23B 349M 2.44B 954M 11.99B 913M 893M 38.57B | EV / Sales 2026 * |
4.9x | EV / Sales 2027 * | 4.26x |
| Free-Float |
57.46% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cipher Pharmaceuticals Inc
| 1 day | -22.72% |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Mull
CEO | Chief Executive Officer | - | 29/07/2019 |
Ryan Mailling
DFI | Director of Finance/CFO | - | 10/08/2024 |
Bryan Jacobs
DFI | Director of Finance/CFO | - | 15/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Mull
CHM | Chairman | - | 12/06/2019 |
Douglas Deeth
BRD | Director/Board Member | 78 | 21/06/2023 |
Hubert Walinski
BRD | Director/Board Member | - | 21/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -22.72% | -5.31% | - | - | 243M | |
| +0.28% | +3.46% | +41.89% | +93.71% | 1,054B | |
| +0.88% | +4.27% | +38.28% | +68.70% | 636B | |
| +1.68% | +5.78% | +21.96% | +89.56% | 497B | |
| -0.10% | +4.24% | +69.15% | +40.41% | 359B | |
| +1.63% | +4.72% | +26.27% | +43.62% | 345B | |
| +1.49% | +3.99% | +16.61% | +39.24% | 273B | |
| +2.15% | +2.88% | -3.32% | +12.10% | 246B | |
| +0.65% | +3.62% | +43.93% | +46.50% | 226B | |
| -0.49% | +4.01% | +28.38% | +95.97% | 187B | |
| Average | -1.24% | +3.14% | +31.46% | +58.87% | 424.69B | |
| Weighted average by Cap. | +0.91% | +3.19% | +34.59% | +67.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 70.85M 49.63M 44.43M 41.41M 37.56M 4.74B 71.29M 498M 195M 2.45B 186M 182M 7.88B | 81.35M 56.98M 51.01M 47.55M 43.13M 5.45B 81.86M 571M 224M 2.81B 214M 209M 9.05B |
| Net income | 27.7M 19.4M 17.37M 16.19M 14.69M 1.85B 27.87M 195M 76.17M 957M 72.88M 71.27M 3.08B | 31.76M 22.25M 19.92M 18.57M 16.84M 2.13B 31.96M 223M 87.34M 1.1B 83.57M 81.72M 3.53B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
